Hot Products
-
Protein L Resin For Affinity Capture
5/3/2023
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
Hyclone Cell Boost Supplements
9/21/2020
Supplements cell culture with amino acids, vitamins, and glucose and manufactured to meet cGMP manufacturing standards and QC specifications.
-
Chromatography Systems
ÄKTA™ chromatography systems can handle both simple and complex purification tasks and accelerate daily routines. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation.
-
Bioprocessing Filtration
11/9/2012
Cytiva provides filtration solutions and support for integrated bioprocessing applications at every step and every scale of the drug development, validation and manufacturing process.
-
Label-Free Interaction Analytics
11/9/2012
We offer a range of systems, accessories, and reagents for label-free analysis using microcalorimetry or surface plasmon resonance (SPR). These techniques provide information-rich, real time data without the use of labels.
-
A High-Capacity Chromatography Resin For Robust mAb Capture
7/31/2025
Protein A chromatography resin with excellent capacity and alkaline stability for cost-efficient and extremely robust mAb capture.
-
Drug Product Filtration System
5/2/2025
Automated PUPSIT and sterile filtration with enhanced product recovery.
-
ReadyToProcess WAVE™ 25 Bioreactor System
2/24/2025
The ReadyToProcess WAVE 25 rocker features integrated temperature sensors and load cells, designed for convenient handling and control of cell cultures up to 25 L. A filter heater is delivered with the system.
-
Protein A Resin With High Binding Capacity
2/21/2025
Protein A resin with high binding capacity for cost-efficient separation mAbs.
-
Modular Environments For Biomanufacturing Capacity
9/16/2024
Accelerate your biomanufacturing capacity with purpose-built modules
KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.